Ken Takeshita (Kite)
Kite development head Ken Takeshita jumps to Daiichi Sankyo amid oncology push
Months after leading Kite Pharma to a landmark OK and establishing the first-ever commercial CAR-T portfolio, global development head Ken Takeshita vaguely announced he was …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.